Drug-induced effects on cardiovascular function in pentobarbital anesthetized guinea-pigs: Invasive LVP measurements versus the QA interval

Journal of Pharmacological and Toxicological Methods

Volumn 66, Issue 2, 2012, Pages 152-159

  Johnson, D M ^a   Geys, R ^a   Lissens, J ^a   Guns, P J ^a  

^a Bio Plus Safety Pharmacology   (Belgium)

Author keywords

Cardiac performance; Guinea pig; Hemodynamics; ICH S7A; LVP; Methods

Indexed keywords

ADRENALIN; AMIODARONE; ISOPRENALINE; NITROPRUSSIDE SODIUM; PENTOBARBITAL; PHENYLEPHRINE; SALBUTAMOL; VERAPAMIL; ZATEBRADINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR PARAMETERS; CONTINUOUS INFUSION; ELECTROCARDIOGRAM; FEMALE; GUINEA PIG; HEART FUNCTION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE PRESSURE; HEART MUSCLE CONTRACTILITY; HEART PERFORMANCE; HEART RATE; HEART REPOLARIZATION; NONHUMAN;

ANESTHESIA; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CARDIOVASCULAR SYSTEM; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; ELECTROCARDIOGRAPHY; FEMALE; GUIDELINES AS TOPIC; GUINEA PIGS; HEART RATE; MYOCARDIAL CONTRACTION; PHARMACEUTICAL PREPARATIONS; TOXICITY TESTS; VENTRICULAR FUNCTION, LEFT;

ANIMALIA; CAVIA;

EID: 84865661585     PISSN: 10568719     EISSN: 1873488X     Source Type: Journal    
DOI: 10.1016/j.vascn.2012.07.002     Document Type: Article

References (32)

1. Adeyemi O., Roberts S., Harris J., West H., Shome S., Dewhurst M. QA interval as an indirect measure of cardiac contractility in the conscious telemeterised rat: Model optimisation and evaluation. Journal of Pharmacological and Toxicological Methods 2009, 60:159-166.
2. Cambridge D., Whiting M.V. Evaluation of the QA interval as an index of cardiac contractility in anaesthetised dogs: Responses to changes in cardiac loading and heart rate. Cardiovascular Research 1986, 20:444-450.
3. Chiba S., Tsuboi M. Dominant anti-vagal effect of pentobarbital on cardiac responses to intracardiac autonomic nerve stimulation in the dog. Japanese Journal of Pharmacology 2001, 86:248-250.
4. Du Plooy W.J., Hay L., Kahler C.P., Schutte P.J., Brandt H.D. The dose-related hyper-and-hypokalaemic effects of salbutamol and its arrhythmogenic potential. British Journal of Pharmacology 1994, 111:73-76.
5. El-Amrani F., Martel E., Richard S. QA interval, as an index of contractility using telemetric measurement in conscious cynomolgus monkeys (Macaca fascicularis). Journal of Pharmacological and Toxicological Methods 2008, 58:158-159.
6. Faivre J.F., Calmels T.P., Rouanet S., Javré J.L., Cheval B., Bril A. Characterisation of Kv4.3 in HEK293 cells: Comparison with the rat ventricular transient outward potassium current. Cardiovascular Research 1999, 41:188-199.
7. Guns P.J., Johnson D.M., Van Op den Bosch J., Weltens E., Lissens J. The electro-mechanical window in anaesthetized guinea-pigs: A new marker for Torsade de Pointes risk screening. British Journal of Pharmacology 2012, 166:689-701.
8. Hamlin R.L., del Rio C. An approach to the assessment of drug-induced changes in non-electrophysiological properties of cardiovascular function. Journal of Pharmacological and Toxicological Methods 2010, 62:20-29.
9. Hamlin R.L., Del Rio C. dP/dt(max)-A measure of 'baroinometry'. Journal of Pharmacological and Toxicological Methods 2012, 66:63-65. (this issue).
10. Hamlin R.L., Kijtawornrat A., Keene B.W., Hamlin D.M. QT and RR intervals in conscious and anesthetized guinea pigs with highly varying RR intervals and given QTc-lengthening test articles. Toxicological Sciences 2003, 76:437-442.
11. Hauser D.S., Stade M., Schmidt A., Hanauer G. Cardiovascular parameters in anaesthetized guinea pigs: A safety pharmacology screening model. Journal of Pharmacological and Toxicological Methods 2005, 52:106-114.
12. Hess P., Rey M., Wanner D., Steiner B., Clozel M. Measurements of blood pressure and electrocardiogram in conscious freely moving guinea pigs: A model for screening QT interval prolongation effects. Laboratory Animals 2007, 41:470-480.
13. Kagstrom J., Sjogren E.L., Ericson A.C. Evaluation of the guinea pig monophasic action potential (MAP) assay in predicting drug-induced delay of ventricular repolarisation using 12 clinically documented drugs. Journal of Pharmacological and Toxicological Methods 2007, 56:186-193.
14. Laverty H., Benson C., Cartwright E., Cross M., Garland C., Hammond T., et al. How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?. British Journal of Pharmacology 2011, 163:675-693.
15. Lewington S., Clarke R., Qizilbash N., Peto R., Collins R. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002, 360:1903-1913.
16. Markert M., Klumpp A., Trautmann T., Mayer K., Stubhan M., Guth B. The value added by measuring myocardial contractility 'in vivo' in safety pharmacological profiling of drug candidates. Journal of Pharmacological and Toxicological Methods 2007, 56:203-211.
17. Mooney L., Marks L., Philp K.L., Skinner M., Coker S.J., Currie S. Optimising conditions for studying the acute effects of drugs on indices of cardiac contractility and on haemodynamics in anaesthetized guinea pigs. Journal of Pharmacological and Toxicological Methods 2012, 10.1016/j.vascn.2012.05.008.
18. Ngo J. Correlation between dP/dtmax and QA interval, two cardiac contractility parameters, in the anesthetized rat. Journal of Pharmacological and Toxicological Methods 2009, 60:211.
19. Norton K., Iacono G., Vezina M. Assessment of the pharmacological effects of inotropic drugs on left ventricular pressure and contractility: An evaluation of the QA interval as an indirect indicator of cardiac inotropism. Journal of Pharmacological and Toxicological Methods 2009, 60:193-197.
20. Paul L., Hastie C.E., Li W.S., Harrow C., Muir S., Connell J.M., et al. Resting heart rate pattern during follow-up and mortality in hypertensive patients. Hypertension 2010, 55:567-574.
21. Prior H., McMahon N., El Amrani F., Martel E., Richard S., Valentin J.P. The QA interval as an indirect measure of inotropic state in conscious dogs. Journal of Pharmacological and Toxicological Methods 2007, 56:e51.
22. Sakaguchi Y., Sugiyama A., Takao S., Akie Y., Takahara A., Hashimoto K. Halothane sensitizes the guinea-pig heart to pharmacological IKr blockade: Comparison with urethane anesthesia. Journal of Pharmacological Sciences 2005, 99:185-190.
23. Sarazan R.D., Mittelstadt S., Guth B., Koerner J., Zhang J., Pettit S. Cardiovascular function in nonclinical drug safety assessment: Current issues and opportunities. International Journal of Toxicology 2011, 30:272-286.
24. Shiotani M., Harada T., Abe J., Hamada Y., Horii I. Aging-related changes of QT and RR intervals in conscious guinea pigs. Journal of Pharmacological and Toxicological Methods 2008, 57:23-29.
25. Takahara A., Sugiyama A., Hashimoto K. Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation. British Journal of Pharmacology 2005, 146:561-567.
26. Takahara A., Sugiyama A., Hashimoto K. Characterization of the halothane-anesthetized guinea-pig heart as a model to detect the K+ channel blocker-induced QT-interval prolongation. Biological and Pharmaceutical Bulletin 2006, 29:827-829.
27. Testai L., Calderone V., Salvadori A., Breschi M.C., Nieri P., Martinotti E. QT prolongation in anaesthetized guinea-pigs: An experimental approach for preliminary screening of torsadogenicity of drugs and drug candidates. Journal of Applied Toxicology 2004, 24:217-222.
28. U.S. Food & Drug Administration ICH S7A safety pharmacology studies for human pharmaceuticals. Guidance for Industry. Federal Register 2001, 66:36791-36792.
29. U.S. Food & Drug Administration Guidance for Industry: ICH S7B Nonclinical evaluation of the potential for delayed ventricular repolarization (QT interval prolongation) by human pharmaceuticals. Federal Register 2005, 70:61133-61134.
30. Van Deuren B., Van Ammel K., Somers Y., Cools F., Straetemans R., van der Linde H.J., et al. The fentanyl/etomidate-anaesthetised beagle (FEAB) dog: A versatile in vivo model in cardiovascular safety research. Journal of Pharmacological and Toxicological Methods 2009, 60:11-23.
31. Yao X., Anderson D.L., Ross S.A., Lang D.G., Desai B.Z., Cooper D.C., et al. Predicting QT prolongation in humans during early drug development using hERG inhibition and an anaesthetized guinea-pig model. British Journal of Pharmacology 2008, 154:1446-1456.
32. Yin F.C., Spurgeon H.A., Greene H.L., Lakatta E.G., Weisfeldt M.L. Age-associated decrease in heart rate response to isoproterenol in dogs. Mechanisms of Ageing and Development 1979, 10:17-25.